A consolidated putative class action alleging Tyson Foods Inc. misled consumers by marketing chicken as “Raised Without Antibiotics” will be heard by a judge in Maryland federal court despite Tyson’s contention that the judge could be unfair to the company.
A federal judge has dismissed another case from the multidistrict litigation over Bayer Corp.'s Baycol, ruling inadmissible the testimony of the plaintiffs' medical expert that linked their injuries to the cholesterol-lowering drug.
Nonprofit researchers called for increased scrutiny of Pfizer Inc.’s Chantix following reports that the smoking-cessation drug had caused more serious injuries than any other drug in the first quarter.
In light of a series of safety scares over Chinese goods, the United Nations has urged the country to overhaul its food review system, and Wal-Mart Stores Inc., the world’s top retailer, has issued stricter product quality standards for suppliers.
Telecommunications company Ericsson Inc. did not violate federal environmental cleanup laws when it sold off an industrial site and left behind an inactive, asbestos-containing boiler system, an appeals court has affirmed.
Ohio's highest court upheld a grant of summary judgment against an asbestos plaintiff Wednesday and ruled that its 1977 decision holding nonmanufacturing sellers of defective products to strict liability should only apply prospectively.
U.S. Special Counsel Scott J. Bloch, in charge of pursuing whistleblower suits, has announced that he will resign when his five-year term ends on Jan. 5, a move that has been welcomed by critics who allege that he has retaliated against his own employees.
The U.S. Food and Drug Administration is keeping inaccurate records of the number of foreign establishments approved to send drugs to the United States and how many it inspects every year, and is failing to force those establishments to re-register once they expire, a Government Accountability Office study has found.
A group of state attorneys general yet to settle with Eli Lilly & Co. over its allegedly fraudulent marketing of Zyprexa has been urged by a judge to sit down at the negotiating table.
A New Jersey state jury has awarded a woman $3 million after determining that Wyeth's diet drug Pondimin, one of the two drugs that constitute fen-phen, caused her to develop a life-threatening lung disease. The verdict comes less than two weeks after Wyeth prevailed in a similar case in Pennsylvania.
Federal regulators are urging parents to inspect the hardware and stability of their children's cribs after two infant deaths prompted Delta Enterprise Corp. Tuesday to recall about 1.6 million drop-side cribs with missing or defective parts.
A Florida motorist has filed a putative class action against Chrysler LLC for what she claims is a “catastrophic” design defect in the engines of thousands of cars manufactured by the automaker between 1998 and 2004.
A federal appeals court on Monday ruled against Industrial Risk Insurers Inc. in its attempt to recoup from Citigroup Inc. and others $861 million in payments in the wake of the Sept. 11, 2001, terrorist attacks that claimed 7 World Trade Center among other New York buildings.
The U.S. Food and Drug Administration published a letter Tuesday that it had sent to Steris Corp., warning that the medical-device sterilization company wasn't complying with “good manufacturing” regulations and could face penalties.
Hyundai Motor Co. has issued two separate recalls for more than 150,000 Elantra vehicles, following a U.S. government inspection that yielded several potential defects relating to the cars' airbag warning-light system.
The magistrate judge serving as special master in the multidistrict litigation against Medtronic Inc. over implantable defibrillators has entered a report and recommendation in support of awarding $18.25 million in common benefit fees to plaintiffs' counsel.
About one-quarter of biotechnology drugs approved in the the U.S. and European Union have been subject to safety-related regulatory actions within their first decade on the market, a new study has shown.
Eli Lilly & Co. will take a $1.4 billion charge in the third quarter to brace for a possible impending settlement with the U.S. Attorney's Office for the Eastern District of Pennsylvania and 30 states regarding the company's promotion and marketing of the anti-psychotic treatment Zyprexa, the company said Tuesday.
After tainted Chinese milk products led to the deaths of four infants, Hong Kong is moving to shore up food-safety checks and give its regulator more power to recall and ban imports.
A lawyer for Exxon Mobil Corp. apologized to Maryland residents Wednesday in a trial stemming from a $1 billion lawsuit over an undetected gas leak at a service station that contaminated surrounding groundwater supplies, but said the company shouldn't be on the hook for punitive damages.